Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.
Menu

Tela Bio Inc (TELA)

Tela Bio Inc (TELA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch Watch
Help
Go To:
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative GlobeNewswire - Mon Aug 31, 6:00AM CDT

Company to reduce annual operating expenses by $17.0 million or 18% as part of broader efficiency program

TELA : 0.7904 (-0.11%)
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative GlobeNewswire - Mon Aug 31, 6:00AM CDT

MALVERN, Pa., Aug. 31, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...

TELA : 0.7904 (-0.11%)
TELA Bio Reports Second Quarter 2026 Financial Results GlobeNewswire - Mon Aug 10, 3:05PM CDT

MALVERN, Pa., Aug. 10, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today...

TELA : 0.7904 (-0.11%)
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Wed Aug 5, 3:05PM CDT

MALVERN, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...

TELA : 0.7904 (-0.11%)
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Wed Aug 5, 3:05PM CDT

MALVERN, Pa., Aug. 05, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...

TELA : 0.7904 (-0.11%)
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director GlobeNewswire - Tue Aug 4, 6:00AM CDT

MALVERN, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...

TELA : 0.7904 (-0.11%)
BFLY : 7.71 (-5.75%)
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director GlobeNewswire - Tue Aug 4, 6:00AM CDT

MALVERN, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on...

TELA : 0.7904 (-0.11%)
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference GlobeNewswire - Wed Jul 29, 3:05PM CDT

MALVERN, Pa., July 29, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...

TELA : 0.7904 (-0.11%)
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference GlobeNewswire - Wed Jul 29, 3:05PM CDT

MALVERN, Pa., July 29, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...

TELA : 0.7904 (-0.11%)
TELA Bio to Announce Second Quarter 2026 Financial Results GlobeNewswire - Mon Jul 20, 3:05PM CDT

MALVERN, Pa., July 20, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...

TELA : 0.7904 (-0.11%)

Barchart Exclusives

How to Play SKHY Stock as SK hynix Looks to Build a New Plant in Japan Barchart - 19 minutes ago
SK hynix could be laying the groundwork for its next growth phase with its potential Japan expansion. Is SKHY now a buy, sell, or hold? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.